Skip to main navigation Skip to search Skip to main content

A novel sarcoidosis risk locus for europeans on chromosome 11q13.1

  • Annegret Fischer
  • , Benjamin Schmid
  • , David Ellinghaus
  • , Michael Nothnagel
  • , Karoline I. Gaede
  • , Manfred Schürmann
  • , Simone Lipinski
  • , Philip Rosenstiel
  • , Gernot Zissel
  • , Kerstin Höhne
  • , Martin Petrek
  • , Vitezslav Kolek
  • , Stefan Pabst
  • , Christian Grohé
  • , Johan Grunewald
  • , Marcus Ronninger
  • , Anders Eklund
  • , Leonid Padyukov
  • , Christian Gieger
  • , H. Erich Wichmann
  • Almut Nebel, Andre Franke, Joachim Müller-Quernheim, Sylvia Hofmann, Stefan Schreiber*
*Corresponding author for this work
  • University of Kiel
  • Airway Research Center North
  • University of Freiburg
  • Laboratory of Immunogenomics and Immunoproteomics
  • Department of Respiratory Medicine
  • Palacky University
  • Medical Clinic II
  • University of Bonn
  • Hannover Medical School
  • Evangelische Lungenklinik
  • Respiratory Medicine Unit
  • Atheros-clerosis Research Unit
  • Karolinska Institutet
  • Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
  • Institute of Medical Informatics, Biometry and Epidemiology
  • Ludwig-Maximilians-Universität

Abstract

Rationale: Sarcoidosis is a complex inflammatory disease with a heterogeneous clinical picture. Among others, an acute and chronic clinical course can be distinguished, for which specific genetic risk factors are known. Objectives: To identify additional risk loci for sarcoidosis and its acute and chronic subforms, we analyzed imputed data from a genomewide association scan for these phenotypes. Methods: After quality control, the genome-wide association scan comprised nearly 1.3 million imputed single-nucleotide polymorphisms based on an Affymetrix 6.0 Gene Chip dataset of 564 German sarcoidosis cases, including 176 acute and 354 chronic cases and 1,575 control subjects. Measurements and Main Results:We identified chromosome 11q13.1 (rs479777) as a novel locus influencing susceptibility to sarcoidosis with genome-wide significance. The marker was significantly associated in three distinct German case-control populations and in an additional German family sample with odds ratios ranging from 0.67 to 0.77. This finding was further replicated in two independent European case-control populations from the Czech Republic (odds ratio, 0.75) and from Sweden (odds ratio, 0.79). In a meta-analysis of the included European case-control samples the marker yielded a P value of 2.68 3 10-18. The locus was previously reported to be associated with Crohn disease, psoriasis, alopecia areata, and leprosy. For sarcoidosis, fine-mapping and expression analysis suggest KCNK4, PRDX5, PCLB3, and most promising CCDC88B as candidates for the underlying risk gene in the associated region. Conclusions: This study provides striking evidence for association of chromosome 11q13.1 with sarcoidosis in Europeans, and thus identified a further genetic risk locus sharedby sarcoidosis, Crohndisease and psoriasis.

Original languageEnglish
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume186
Issue number9
Pages (from-to)877-885
Number of pages9
ISSN1073-449X
DOIs
Publication statusPublished - 01.11.2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A novel sarcoidosis risk locus for europeans on chromosome 11q13.1'. Together they form a unique fingerprint.

Cite this